Literature DB >> 29872899

Rare childhood hybrid histiocytosis of the central nervous system-diagnosed by stereotactic brain biopsy with marked treatment response to clofarabine.

J Foss-Skiftesvik1, D Scheie2, C Klausen3, A Sehested4, J Skjøth-Rasmussen5.   

Abstract

Histiocytosis is a heterogeneous group of disease entities, comprised by two main categories, namely Langerhans and non-Langerhans cell histiocytoses. Central nervous system involvement in histiocytosis is considered very rare and is often secondary to affection of anatomically related bone structures and/or multi-organ disease. We present a never-before described case of rare childhood histiocytosis with hybrid features of Langerhans cell histiocytosis and juvenile xanthogranuloma confined to the central nervous system in a 2- and a half-year-old boy with distinct treatment response to clofarabine. The case also emphasizes the diagnostic significance of stereotactic brain biopsy.

Entities:  

Keywords:  Central nervous system (CNS); Clofarabine; Histiocytosis; Juvenile xanthogranuloma (JXG); Langerhans cell histiocytosis (LCH)

Mesh:

Substances:

Year:  2018        PMID: 29872899     DOI: 10.1007/s00381-018-3859-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry.

Authors:  Dirk Janssen; Dieter Harms
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

2.  [Juvenile multiple xanthogranuloma in a patient with Langerhans cell histiocytosis].

Authors:  S Pérez-Gala; A Torrelo; I Colmenero; T Contra; L Madero; A Zambrano
Journal:  Actas Dermosifiliogr       Date:  2006-11

3.  Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments.

Authors:  Ashish Bains; David M Parham
Journal:  Pediatr Dev Pathol       Date:  2011-07-27

4.  Risk factors for diabetes insipidus in langerhans cell histiocytosis.

Authors:  N Grois; U Pötschger; H Prosch; M Minkov; M Arico; J Braier; J-I Henter; G Janka-Schaub; S Ladisch; J Ritter; M Steiner; E Unger; H Gadner
Journal:  Pediatr Blood Cancer       Date:  2006-02       Impact factor: 3.167

5.  The use of Brainsuite iCT for frame-based stereotactic procedures.

Authors:  Jane Skjøth-Rasmussen; Bo Jespersen; Jannick Brennum
Journal:  Acta Neurochir (Wien)       Date:  2015-07-08       Impact factor: 2.216

Review 6.  Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review.

Authors:  Johanna D Strehl; Klaus-Daniel Stachel; Arndt Hartmann; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

7.  Neuropathology of CNS disease in Langerhans cell histiocytosis.

Authors:  Nicole Grois; Daniela Prayer; Helmut Prosch; Hans Lassmann
Journal:  Brain       Date:  2005-02-10       Impact factor: 13.501

8.  Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations.

Authors:  Louis P Dehner
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

9.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

10.  Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.

Authors:  Annalisa Patrizi; Iria Neri; Federica Bianchi; Valentina Guerrini; Cosimo Misciali; Giuseppina Paone; Roberta Burnelli
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.